Skip to content
Screener

Design Therapeutics, Inc. DSGN Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

ALN
Alnylam PharmaceuticalsALNY
$183.36M-4.7%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$85.95M-33.4%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$128.67M-8.3%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$19.65M-17.7%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$5.04M-15.3%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$6.32M-18.7%

Other financials

Income statement

See full
Revenue-
Operating income-$19.7M+3.5%
Net income-$17.6M+0.4%
EPS (diluted)-$0.29+6.5%

Balance sheet

See full
Cash & equivalents$12.8M-6.6%
Total debt$2.7M+27.7%
Total equity$218.1M-4.3%
Total assets$230.4M-3.0%

Cash flow

See full
Operating cash flow-$16.4M+2.1%
CapEx--100%
Free cash flow-$16.4M+2.6%

Valuation

See full
Market cap$896.8M+227%
Enterprise value$886.76M+245%

Profitability

See full
Operating margin-3,685.8%
Net margin-3,663.7%

Returns & leverage

See full
Return on equity-31.3%+19.5pp
Debt / equity0.0×
Current ratio22.3×-6.1×

Where this comes from

Reported directly by Design Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026.

Filed
Apr 28, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-187063
Line itemMarch 31, 2026December 31, 2025
Prepaid expenses and other current assets4,2263,939
Total current assets227,049223,784
Property and equipment, net824981
Right-of-use asset2,5691,438
Total assets$230,442$226,203
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$2,276$2,312

Item 1. Financial Statements.

FAQ

What is Design Therapeutics, Inc.'s operating lease ROU assets?
Design Therapeutics, Inc. (DSGN) reported operating lease ROU assets of $2.57M in Q1 2026.
How has Design Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
Design Therapeutics, Inc.'s operating lease ROU assets increased by 26.7% year-over-year, from $2.03M to $2.57M.
What is the long-term trend for Design Therapeutics, Inc.'s operating lease ROU assets?
Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s operating lease ROU assets has grown at a -20.6% compound annual growth rate (CAGR), from $3.61M to $1.44M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Design Therapeutics, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude